For the year ending 2025-12-31, AGIO has $1,297,225K in assets. $104,111K in debts. $89,130K in cash and cash equivalents.
| Balance Sheets | 2025-12-31 | |||
|---|---|---|---|---|
| Cash and cash equivalents | 89,130 | |||
| Marketable securities | 765,295 | |||
| Accounts receivable, net | 10,577 | |||
| Inventory | 32,920 | |||
| Prepaid expenses and other current assets | 44,130 | |||
| Total current assets | 942,052 | |||
| Marketable securities | 310,013 | |||
| Operating lease assets | 30,454 | |||
| Property and equipment, net | 10,775 | |||
| Other non-current assets | 3,931 | |||
| Total assets | 1,297,225 | |||
| Accounts payable | 18,355 | |||
| Accrued expenses | 45,459 | |||
| Income taxes payable | 0 | |||
| Operating lease liabilities | 18,392 | |||
| Total current liabilities | 82,206 | |||
| Operating lease liabilities, net of current portion | 21,815 | |||
| Other non-current liabilities | 90 | |||
| Total liabilities | 104,111 | |||
| Common stock, 0.001 par value 125,000,000 shares authorized 74,665,003 shares issued and 58,448,592 outstanding at december 31, 2025 and 73,372,696 shares issued and 57,156,285 outstanding at december 31, 2024 | 75 | |||
| Additional paid-in capital | 2,555,037 | |||
| Accumulated other comprehensive income (loss) | 2,193 | |||
| Accumulated deficit | -561,705 | |||
| Treasury stock, at cost (16,216,411 shares at december 31, 2025 and december 31, 2024) | 802,486 | |||
| Total stockholders equity | 1,193,114 | |||
| Total liabilities and stockholders equity | 1,297,225 | |||
AGIOS PHARMACEUTICALS, INC. (AGIO)
AGIOS PHARMACEUTICALS, INC. (AGIO)